Entity | Amount | Change
09/30/2023 to 12/31/2023 |
Position Size ($ in 1000's) |
---|---|---|---|
Neurocrine Biosciences Inc | 800,000 | +800,000 | $105,408 |
NBIX | 800,000 | +800,000 | $105,408 |
Jazz Pharmaceuticals PLC | 725,000 | +725,000 | $89,175 |
JAZZ | 725,000 | +725,000 | $89,175 |
Ascendis Pharma A S | 625,000 | +625,000 | $78,719 |
ASND | 625,000 | +625,000 | $78,719 |
Inhibrx Inc | 1,530,000 | +1,530,000 | $58,140 |
INBX | 1,530,000 | +1,530,000 | $58,140 |
Soleno Therapeutics Inc | 1,300,000 | +1,300,000 | $52,325 |
SLNO | 1,300,000 | +1,300,000 | $52,325 |
Merck & Co Inc | 400,000 | +400,000 | $43,608 |
MRK | 400,000 | +400,000 | $43,608 |
Globus Medical Inc | 800,000 | +800,000 | $42,632 |
GMED | 800,000 | +800,000 | $42,632 |
Pacira BioSciences Inc | 1,200,000 | +1,200,000 | $40,488 |
PCRX | 1,200,000 | +1,200,000 | $40,488 |
Cymabay Therapeutics Inc | 1,625,000 | +1,625,000 | $38,382 |
CBAY | 1,625,000 | +1,625,000 | $38,382 |
Vaxcyte Inc | 525,000 | +525,000 | $32,970 |
PCVX | 525,000 | +525,000 | $32,970 |
Insmed Inc | 900,000 | +900,000 | $27,891 |
INSM | 900,000 | +900,000 | $27,891 |
uniQure NV | 3,925,000 | +3,925,000 | $26,572 |
QURE | 3,925,000 | +3,925,000 | $26,572 |
ALX Oncology Holdings Inc | 1,655,000 | +1,655,000 | $24,643 |
ALXO | 1,655,000 | +1,655,000 | $24,643 |
Immatics NV | 2,100,000 | +2,100,000 | $22,113 |
IMTX | 2,100,000 | +2,100,000 | $22,113 |
Viridian Therapeutics Inc | 1,000,000 | +1,000,000 | $21,780 |
VRDN | 1,000,000 | +1,000,000 | $21,780 |
REVOLUTION Medicines Inc | 725,000 | +725,000 | $20,793 |
RVMD | 725,000 | +725,000 | $20,793 |
Biogen Inc | 75,000 | +75,000 | $19,408 |
BIIB | 75,000 | +75,000 | $19,408 |
Edwards Lifesciences Corp | 225,000 | +225,000 | $17,156 |
EW | 225,000 | +225,000 | $17,156 |
AstraZeneca PLC | 250,000 | +250,000 | $16,838 |
AZN | 250,000 | +250,000 | $16,838 |
Crinetics Pharmaceuticals Inc | 450,000 | +450,000 | $16,011 |
CRNX | 450,000 | +450,000 | $16,011 |
Lyra Therapeutics Inc | 3,000,000 | +3,000,000 | $15,720 |
LYRA | 3,000,000 | +3,000,000 | $15,720 |
Sanofi SA | 300,000 | +300,000 | $14,919 |
SNY | 300,000 | +300,000 | $14,919 |
Nuvalent Inc | 200,000 | +200,000 | $14,718 |
NUVL | 200,000 | +200,000 | $14,718 |
Applied Therapeutics Inc | 4,155,000 | +4,155,000 | $13,919 |
APLT | 4,155,000 | +4,155,000 | $13,919 |
Liquidia Corp | 1,025,000 | +1,025,000 | $12,331 |
LQDA | 1,025,000 | +1,025,000 | $12,331 |
Aerovate Therapeutics Inc | 400,000 | +400,000 | $9,052 |
AVTE | 400,000 | +400,000 | $9,052 |
Regeneron Pharmaceuticals Inc | 10,000 | +10,000 | $8,783 |
REGN | 10,000 | +10,000 | $8,783 |
Arcutis Biotherapeutics Inc | 2,700,000 | +2,700,000 | $8,721 |
ARQT | 2,700,000 | +2,700,000 | $8,721 |
Xenon Pharmaceuticals Inc | 175,000 | +175,000 | $8,060 |
XENE | 175,000 | +175,000 | $8,060 |
Fulcrum Therapeutics Inc | 1,025,000 | +1,025,000 | $6,919 |
FULC | 1,025,000 | +1,025,000 | $6,919 |
Alnylam Pharmaceuticals Inc | 35,000 | +35,000 | $6,699 |
ALNY | 35,000 | +35,000 | $6,699 |
Galapagos NV | 130,000 | +130,000 | $5,284 |
GLPG | 130,000 | +130,000 | $5,284 |
Fate Therapeutics Inc | 1,290,000 | +1,290,000 | $4,825 |
FATE | 1,290,000 | +1,290,000 | $4,825 |
Cytokinetics Inc | 50,000 | +50,000 | $4,174 |
CYTK | 50,000 | +50,000 | $4,174 |
Arcellx Inc | 60,000 | +60,000 | $3,330 |
ACLX | 60,000 | +60,000 | $3,330 |
Bluebird Bio Inc | 2,150,000 | +2,150,000 | $2,967 |
BLUE | 2,150,000 | +2,150,000 | $2,967 |
Teva Pharmaceutical Industries | 200,000 | +200,000 | $2,088 |
TEVA | 200,000 | +200,000 | $2,088 |
Dianthus Therapeutics Inc | 135,000 | +135,000 | $1,404 |
DNTH | 135,000 | +135,000 | $1,404 |
Chimerix Inc | 1,400,000 | +1,400,000 | $1,348 |
CMRX | 1,400,000 | +1,400,000 | $1,348 |
Pyxis Oncology Inc | 440,000 | +440,000 | $792 |
PYXS | 440,000 | +440,000 | $792 |
Reneo Pharmaceuticals Inc | 400,000 | +400,000 | $640 |
RPHM | 400,000 | +400,000 | $640 |
Ikena Oncology Inc | 322,671 | +322,671 | $636 |
IKNA | 322,671 | +322,671 | $636 |
Relmada Therapeutics Inc | 115,000 | +115,000 | $476 |
RLMD | 115,000 | +115,000 | $476 |
Affimed NV | 546,067 | +546,067 | $341 |
AFMD | 546,067 | +546,067 | $341 |
Ovid therapeutics Inc | 85,429 | +85,429 | $275 |
OVID | 85,429 | +85,429 | $275 |
Solid Biosciences Inc | 34,085 | +34,085 | $209 |
SLDB | 34,085 | +34,085 | $209 |
Prime Medicine Inc | 20,306 | +20,306 | $180 |
PRME | 20,306 | +20,306 | $180 |
See Full List: All Stocks Held By Vestal Point Capital LP
— Including:
Biggest new positions
Biggest exits
See Details: Top 10 Stocks Held By Vestal Point Capital LP
Size ($ in 1000's)
At 12/31/2023: $943,958 At 09/30/2023: $0 Vestal Point Capital LP holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from Vestal Point Capital LP 13F filings. Link to 13F filings: SEC filings |